Becton, Dickinson and Company Company Profile (NYSE:BDX)

About Becton, Dickinson and Company (NYSE:BDX)

Becton, Dickinson and Company logoBecton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Supplies
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:BDX
  • CUSIP: 07588710
  • Web: www.bd.com
Capitalization:
  • Market Cap: $44.14761 billion
  • Outstanding Shares: 227,564,000
Average Prices:
  • 50 Day Moving Avg: $199.01
  • 200 Day Moving Avg: $191.58
  • 52 Week Range: $161.29 - $206.63
P/E:
  • Trailing P/E Ratio: 56.11
  • Foreward P/E Ratio: 18.28
  • P/E Growth: 2.07
Sales & Book Value:
  • Annual Revenue: $12.16 billion
  • Price / Sales: 3.58
  • Book Value: $55.30 per share
  • Price / Book: 3.46
Dividend:
  • Annual Dividend: $2.92
  • Dividend Yield: 1.5%
Profitability:
  • EBIDTA: $3.19 billion
  • Net Margins: 6.25%
  • Return on Equity: 22.53%
  • Return on Assets: 7.25%
Debt:
  • Debt-to-Equity Ratio: 1.48%
  • Current Ratio: 5.56%
  • Quick Ratio: 5.01%
Misc:
  • Average Volume: 1.19 million shs.
  • Beta: 1.06
  • Short Ratio: 4.32
 

Frequently Asked Questions for Becton, Dickinson and Company (NYSE:BDX)

What is Becton, Dickinson and Company's stock symbol?

Becton, Dickinson and Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

How often does Becton, Dickinson and Company pay dividends? What is the dividend yield for Becton, Dickinson and Company?

Becton, Dickinson and Company declared a quarterly dividend on Tuesday, July 25th. Stockholders of record on Friday, September 8th will be given a dividend of $0.73 per share on Friday, September 29th. This represents a $2.92 annualized dividend and a dividend yield of 1.52%. The ex-dividend date is Thursday, September 7th. View Becton, Dickinson and Company's Dividend History.

How were Becton, Dickinson and Company's earnings last quarter?

Becton, Dickinson and Company (NYSE:BDX) issued its quarterly earnings results on Thursday, August, 3rd. The company reported $2.46 EPS for the quarter, topping the consensus estimate of $2.44 by $0.02. The company had revenue of $3.04 billion for the quarter, compared to analysts' expectations of $3.06 billion. Becton, Dickinson and Company had a net margin of 6.25% and a return on equity of 22.53%. The company's revenue for the quarter was down 5.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.35 earnings per share. View Becton, Dickinson and Company's Earnings History.

When will Becton, Dickinson and Company make its next earnings announcement?

Becton, Dickinson and Company is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for Becton, Dickinson and Company.

What guidance has Becton, Dickinson and Company issued on next quarter's earnings?

Becton, Dickinson and Company issued an update on its FY17 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $9.42-9.47 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.46. The company issued revenue guidance of decline to 3.0-3.5% to ~$11.99-12.05 billion, compared to the consensus revenue estimate of $12.06 billion.

Where is Becton, Dickinson and Company's stock going? Where will Becton, Dickinson and Company's stock price be in 2017?

15 brokers have issued 1-year price targets for Becton, Dickinson and Company's stock. Their predictions range from $165.00 to $230.00. On average, they anticipate Becton, Dickinson and Company's stock price to reach $197.07 in the next twelve months. View Analyst Ratings for Becton, Dickinson and Company.

What are analysts saying about Becton, Dickinson and Company stock?

Here are some recent quotes from research analysts about Becton, Dickinson and Company stock:

  • 1. According to Zacks Investment Research, "Becton, Dickinson and Company, popularly known as BD, saw a mixed third quarter, wherein adjusted earnings beat the Zacks Consensus Estimate, while revenues missed the same. A solid guidance for fiscal 2017 instills our confidence in the stock. The company is steadily progressing with its planned acquisition of medical technology player, C. R. Bard. The $24-billion transaction is slated to be completed in the fourth quarter. Post completion, BD expects growth in adjusted earnings starting fiscal 2019. We view the acquisition as a strategic fit which will generate benefits from complementary businesses and geographical expansion. BD's cost-control initiatives are also noteworthy. On the flipside, unfavorable sales performance from the BD Medical segment is a concern. Massive growth in the segment was negated by sluggishness in the Medication Management Solutions and Pharmaceutical Systems units in the U.S." (8/7/2017)
  • 2. Citigroup Inc. analysts commented, "We see a diminishing impact on growth from emerging markets, which once contributed over 50 percent of total growth for the company but will likely only contribute about one third of total growth going forward, and as an aside we're slightly cautious on the timing of O-US synergy benefits from CFN. The extra burden will shift to developed markets," (9/23/2016)

Who are some of Becton, Dickinson and Company's key competitors?

Who are Becton, Dickinson and Company's key executives?

Becton, Dickinson and Company's management team includes the folowing people:

  • Vincent A. Forlenza, Chairman of the Board, Chief Executive Officer
  • Thomas E. Polen, President
  • Christopher R. Reidy, Chief Financial Officer, Executive Vice President, Chief Administrative Officer
  • Linda M. Tharby, Chief Human Resource Officer, Executive Vice President
  • Nabil Shabshab, Executive Vice President - Strategic Planning Chief Marketing Officer
  • Jeffrey S. Sherman, Executive Vice President, General Counsel
  • Gary M. Cohen, Executive Vice President and President - Global Health.
  • Alexandre Conroy, Executive Vice President and President, Europe, EMA
  • James Lim, Executive Vice President and President, Greater Asia
  • Alberto Mas, Executive Vice President and President - Life Sciences Segment

Who owns Becton, Dickinson and Company stock?

Becton, Dickinson and Company's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.09%), State Street Corp (4.51%), Northern Trust Corp (1.32%), Fiera Capital Corp (1.30%), Jensen Investment Management Inc. (1.11%) and Fundsmith LLP (1.01%). Company insiders that own Becton, Dickinson and Company stock include Ellen R Strahlman, Gary M Cohen, James C Lim, James F Orr, Jeffrey S Sherman, Jerome V Hurwitz, John E Gallagher, Linda M Tharby, Nabil Shabshab, Rebecca W Rimel, Ribo Alberto Mas, Stephen Sichak, Thomas E Polen Jr, Vincent A Forlenza and William A Kozy. View Institutional Ownership Trends for Becton, Dickinson and Company.

Who sold Becton, Dickinson and Company stock? Who is selling Becton, Dickinson and Company stock?

Becton, Dickinson and Company's stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Boston Partners, American Century Companies Inc., Private Advisor Group LLC, Karp Capital Management Corp, Canada Pension Plan Investment Board, Robeco Institutional Asset Management B.V. and Schwab Charles Investment Management Inc.. Company insiders that have sold Becton, Dickinson and Company stock in the last year include Ellen R Strahlman, Gary M Cohen, Jeffrey S Sherman, John E Gallagher, Linda M Tharby, Nabil Shabshab, Ribo Alberto Mas, Stephen Sichak and Thomas E Polen Jr. View Insider Buying and Selling for Becton, Dickinson and Company.

Who bought Becton, Dickinson and Company stock? Who is buying Becton, Dickinson and Company stock?

Becton, Dickinson and Company's stock was bought by a variety of institutional investors in the last quarter, including Koch Industries Inc., Vanguard Group Inc., Winslow Capital Management LLC, Janus Henderson Group PLC, Parametric Portfolio Associates LLC, Los Angeles Capital Management & Equity Research Inc., Findlay Park Partners LLP and Principal Financial Group Inc.. View Insider Buying and Selling for Becton, Dickinson and Company.

How do I buy Becton, Dickinson and Company stock?

Shares of Becton, Dickinson and Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Becton, Dickinson and Company's stock price today?

One share of Becton, Dickinson and Company stock can currently be purchased for approximately $191.56.


MarketBeat Community Rating for Becton, Dickinson and Company (NYSE BDX)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  283 (Vote Outperform)
Underperform Votes:  397 (Vote Underperform)
Total Votes:  680
MarketBeat's community ratings are surveys of what our community members think about Becton, Dickinson and Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Becton, Dickinson and Company (NYSE:BDX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 9 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $197.07 (2.88% upside)

Analysts' Ratings History for Becton, Dickinson and Company (NYSE:BDX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/22/2017Wells Fargo & CompanyInitiated CoverageOutperform$225.00LowView Rating Details
9/12/2017Piper Jaffray CompaniesReiterated RatingBuy$213.00HighView Rating Details
8/14/2017Cowen and CompanyReiterated RatingBuy$230.00LowView Rating Details
8/10/2017Barclays PLCReiterated RatingEqual Weight$205.00 -> $210.00LowView Rating Details
8/9/2017Stifel NicolausReiterated RatingBuyLowView Rating Details
7/21/2017Bank of America CorporationReiterated RatingBuy$200.00 -> $225.00MediumView Rating Details
6/30/2017Raymond James Financial, Inc.UpgradeOutperform -> Strong-Buy$210.00 -> $180.00LowView Rating Details
4/24/2017Evercore ISIUpgradeIn-Line -> Outperform$186.00 -> $200.00HighView Rating Details
4/13/2017Royal Bank Of CanadaReiterated RatingHold$177.00LowView Rating Details
3/29/2017Jefferies Group LLCReiterated RatingBuy$200.00LowView Rating Details
1/3/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$190.00 -> $175.00N/AView Rating Details
11/21/2016Leerink SwannReiterated RatingMarket Perform$180.00 -> $185.00N/AView Rating Details
11/4/2016Deutsche Bank AGReiterated RatingBuy$197.00 -> $189.00N/AView Rating Details
10/21/2016ArgusReiterated RatingBuy$185.00N/AView Rating Details
9/23/2016Citigroup Inc.DowngradeNeutral -> Sell$167.00 -> $165.00N/AView Rating Details
5/8/2016Morgan StanleyReiterated RatingHoldN/AView Rating Details
4/8/2016Goldman Sachs Group, Inc. (The)Boost Price Target$156.00 -> $157.00N/AView Rating Details
11/19/2015William BlairReiterated RatingOutperformN/AView Rating Details
(Data available from 9/22/2015 forward)

Earnings

Earnings History for Becton, Dickinson and Company (NYSE:BDX)
Earnings by Quarter for Becton, Dickinson and Company (NYSE:BDX)
Earnings History by Quarter for Becton, Dickinson and Company (NYSE BDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017$2.37N/AView Earnings Details
8/3/2017Q3 2017$2.44$2.46$3.06 billion$3.04 billionViewListenView Earnings Details
5/2/2017Q2 2017$2.23$2.30$2.92 billion$2.97 billionViewListenView Earnings Details
2/2/2017Q117$2.11$2.33$2.86 billion$2.92 billionViewListenView Earnings Details
11/3/2016Q416$2.09$2.12$3.22 billion$3.23 billionViewListenView Earnings Details
8/4/2016Q316$2.20$2.35$3.21 billion$3.20 billionViewListenView Earnings Details
5/5/2016Q216$2.02$2.18$3.07 billion$3.07 billionViewListenView Earnings Details
2/3/2016Q116$1.84$1.96$3.04 billion$2.99 billionViewListenView Earnings Details
11/4/2015Q415$1.90$1.94$3.04 billion$3.07 billionViewListenView Earnings Details
8/6/2015Q315$2.01$2.05$3.13 billion$3.12 billionViewListenView Earnings Details
5/7/2015Q2$1.54$1.61$2.05 billion$2.05 billionViewListenView Earnings Details
2/5/2015Q115$1.43$1.53$2.04 billion$2.05 billionViewListenView Earnings Details
11/4/2014Q414$1.65$1.68$2.16 billion$2.20 billionViewListenView Earnings Details
7/31/2014Q314$1.68$1.68$2.14 billion$2.16 billionViewListenView Earnings Details
5/1/2014Q2$1.50$1.53$2.09 billion$2.07 billionViewListenView Earnings Details
2/4/2014Q114$1.30$1.42$1.98 billion$2.00 billionViewListenView Earnings Details
11/5/2013Q413$1.46$1.52$2.05 billion$2.10 billionViewListenView Earnings Details
8/1/2013Q3 2013$1.48$1.58$2.05 million$2.05 billionViewListenView Earnings Details
5/2/2013Q2 2013$1.35$1.44$1.99 billion$2.00 billionViewListenView Earnings Details
2/5/2013Q1 2013$1.24$1.35$1.86 billion$1.90 billionViewListenView Earnings Details
11/7/2012Q412$1.40$1.42$1.96 billion$1.97 billionViewN/AView Earnings Details
8/2/2012$1.53$1.52ViewN/AView Earnings Details
5/1/2012$1.38$1.38ViewN/AView Earnings Details
2/7/2012$1.17$1.21ViewN/AView Earnings Details
11/2/2011$1.41$1.39ViewN/AView Earnings Details
8/2/2011$1.43$1.53ViewN/AView Earnings Details
4/26/2011$1.30$1.38ViewN/AView Earnings Details
2/7/2011$1.29$1.35ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Becton, Dickinson and Company (NYSE:BDX)
2017 EPS Consensus Estimate: $9.10
2018 EPS Consensus Estimate: $10.23
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$2.06$2.10$2.08
Q2 20172$2.20$2.23$2.22
Q3 20172$2.44$2.46$2.45
Q4 20172$2.34$2.37$2.36
Q1 20181$2.28$2.28$2.28
Q2 20181$2.42$2.42$2.42
Q3 20181$2.81$2.81$2.81
Q4 20181$2.72$2.72$2.72
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Becton, Dickinson and Company (NYSE:BDX)
Next Dividend:9/29/2017
Annual Dividend:$2.92
Dividend Yield:1.52%
Dividend Growth:10.10% (3 Year Average)
Payout Ratio:83.43% (Trailing 12 Months of Earnings)
30.87% (Based on This Year's Estimates)
27.86% (Based on Next Year's Estimates)
Track Record:45 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Becton, Dickinson and Company (NYSE:BDX)

Dividend History by Quarter for Becton, Dickinson and Company (NYSE BDX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/25/2017quarterly$0.731.44%9/7/20179/8/20179/29/2017
5/23/2017quarterly$0.731.56%6/7/20176/9/20176/30/2017
1/23/2017quarterly$0.731.71%3/8/20173/10/20173/31/2017
11/21/2016quarterly$0.731.74%12/7/201612/9/201612/30/2016
7/26/2016quarterly$0.661.51%9/7/20169/9/20169/30/2016
5/24/2016quarterly$0.661.58%6/7/20166/9/20166/30/2016
1/25/2016quarterly$0.661.81%3/8/20163/10/20163/31/2016
11/23/2015quarterly$0.661.75%12/8/201512/10/201512/31/2015
7/28/2015quarterly$0.601.58%9/4/20159/9/20159/30/2015
5/19/2015quarterly$0.601.69%6/5/20156/9/20156/30/2015
1/27/2015quarterly$0.601.65%3/6/20153/10/20153/31/2015
11/25/2014quarterly$0.601.7%12/8/201412/10/201412/31/2014
7/22/2014quarterly$0.551.84%9/5/20149/9/20149/30/2014
5/20/2014quarterly$0.551.88%6/5/20146/9/20146/30/2014
1/28/2014quarterly$0.552.02%3/6/20143/10/20143/31/2014
11/26/2013quarterly$0.552%12/6/201312/10/201312/31/2013
7/23/2013quarterly$0.501.91%9/5/20139/9/20139/30/2013
5/21/2013quarterly$0.501.98%6/5/20136/7/20136/28/2013
1/29/2013quarterly$0.502.35%3/6/20133/8/20133/29/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Becton, Dickinson and Company (NYSE:BDX)
Insider Ownership Percentage: 1.40%
Institutional Ownership Percentage: 87.12%
Insider Trades by Quarter for Becton, Dickinson and Company (NYSE:BDX)
Institutional Ownership by Quarter for Becton, Dickinson and Company (NYSE:BDX)
Insider Trades by Quarter for Becton, Dickinson and Company (NYSE:BDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/11/2017Gary M CohenInsiderSell15,512$203.77$3,160,880.24View SEC Filing  
9/8/2017Stephen SichakInsiderSell11,787$200.46$2,362,822.02View SEC Filing  
8/22/2017Gary M CohenInsiderSell15,044$200.43$3,015,268.92View SEC Filing  
8/22/2017Linda M TharbyEVPSell4,695$200.48$941,253.60View SEC Filing  
8/15/2017Nabil ShabshabInsiderSell6,149$201.76$1,240,622.24View SEC Filing  
8/14/2017Ribo Alberto MasEVPSell7,463$201.41$1,503,122.83View SEC Filing  
8/10/2017Ellen R StrahlmanInsiderSell9,283$198.21$1,839,983.43View SEC Filing  
8/9/2017Thomas E Polen JrInsiderSell5,971$197.41$1,178,735.11View SEC Filing  
5/25/2017Jeffrey S ShermanVPSell28,765$185.98$5,349,714.70View SEC Filing  
2/15/2017Jeffrey S ShermanVPSell31,464$180.02$5,664,149.28View SEC Filing  
12/15/2016John E GallagherVPSell1,793$168.82$302,694.26View SEC Filing  
12/5/2016Stephen SichakInsiderSell2,632$164.44$432,806.08View SEC Filing  
11/4/2016Stephen SichakInsiderSell10,352$176.10$1,822,987.20View SEC Filing  
9/6/2016Linda M TharbyInsiderSell11,704$177.27$2,074,768.08View SEC Filing  
8/11/2016Gary M CohenInsiderSell29,367$176.81$5,192,379.27View SEC Filing  
6/13/2016John E GallagherVPSell1,931$169.87$328,018.97View SEC Filing  
6/7/2016Nabil ShabshabEVPSell5,080$168.75$857,250.00View SEC Filing  
5/17/2016Jeffrey S ShermanVPSell34,373$166.27$5,715,198.71View SEC Filing  
5/13/2016Stephen SichakEVPSell12,995$166.48$2,163,407.60View SEC Filing  
5/13/2016Vincent A ForlenzaCEOSell37,933$166.17$6,303,326.61View SEC Filing  
5/10/2016James F OrrDirectorSell1,368$167.66$229,358.88View SEC Filing  
5/9/2016James C LimEVPSell5,257$165.60$870,559.20View SEC Filing  
5/6/2016Ellen R StrahlmanSVPSell3,019$163.52$493,666.88View SEC Filing  
5/6/2016Jerome V HurwitzEVPSell3,878$163.58$634,363.24View SEC Filing  
5/6/2016Rebecca W RimelDirectorSell684$163.69$111,963.96View SEC Filing  
12/14/2015Stephen SichakEVPSell8,670$152.21$1,319,660.70View SEC Filing  
12/9/2015William A KozyEVPSell15,495$154.43$2,392,892.85View SEC Filing  
12/8/2015Vincent A. ForlenzaCEOSell17,762$153.10$2,719,362.20View SEC Filing  
12/7/2015Jeffrey S ShermanVPSell7,586$153.76$1,166,423.36View SEC Filing  
12/1/2015Thomas E Polen JrEVPSell2,683$152.21$408,379.43View SEC Filing  
11/30/2015John E GallagherVPSell1,600$150.70$241,120.00View SEC Filing  
11/18/2015Jerome V. HurwitzEVPSell2,347$151.02$354,443.94View SEC Filing  
6/1/2015Stephen SichakEVPSell12,188$140.94$1,717,776.72View SEC Filing  
5/22/2015Thomas E Polen JrEVPSell3,882$142.56$553,417.92View SEC Filing  
5/21/2015Linda M TharbyEVPSell6,069$142.02$861,919.38View SEC Filing  
5/20/2015William A KozyEVPSell10,326$142.00$1,466,292.00View SEC Filing  
5/19/2015William A KozyEVPSell10,435$142.01$1,481,874.35View SEC Filing  
5/18/2015Bertram L ScottDirectorSell2,160$141.74$306,158.40View SEC Filing  
5/18/2015James C LimEVPSell3,604$141.80$511,047.20View SEC Filing  
5/15/2015Alexandre ConroyEVPSell1,291$141.37$182,508.67View SEC Filing  
5/13/2015Jeffrey S ShermanVPSell10,983$138.40$1,520,047.20View SEC Filing  
5/11/2015Jerome V HurwitzEVPSell1,197$141.43$169,291.71View SEC Filing  
5/8/2015Gary M CohenEVPSell13,490$142.90$1,927,721.00View SEC Filing  
6/12/2014Stephen SichakSVPSell1,456$118.25$172,172.00View SEC Filing  
6/10/2014Gary M CohenEVPSell12,476$119.24$1,487,638.24View SEC Filing  
6/9/2014Jeffrey S ShermanVPSell7,877$120.24$947,130.48View SEC Filing  
3/6/2014Jeffrey ShermanVPSell1,303$115.16$150,053.48View SEC Filing  
11/12/2013William KozyEVPSell9,597$108.30$1,039,355.10View SEC Filing  
11/11/2013Jeffrey ShermanVPSell4,272$107.78$460,436.16View SEC Filing  
11/11/2013Jerome HurwitzSVPSell1,151$107.78$124,054.78View SEC Filing  
11/8/2013Vincent ForlenzaCEOSell32,411$107.39$3,480,617.29View SEC Filing  
11/6/2013Henry Becton, Jr.DirectorSell2,276$106.77$243,008.52View SEC Filing  
8/23/2013Bertram ScottDirectorSell4,047$98.61$399,074.67View SEC Filing  
8/8/2013Edward DegraanDirectorSell4,436$100.03$443,733.08View SEC Filing  
8/8/2013Stephen SichakSVPSell3,431$100.13$343,546.03View SEC Filing  
8/7/2013Basil AndersonDirectorSell2,160$99.79$215,546.40View SEC Filing  
5/22/2013Henry P Becton JrDirectorSell3,117$101.86$317,497.62View SEC Filing  
5/17/2013Donna M BolesVPSell2,415$101.38$244,832.70View SEC Filing  
5/13/2013Gary M CohenEVPSell8,753$100.22$877,225.66View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Becton, Dickinson and Company (NYSE:BDX)
Latest Headlines for Becton, Dickinson and Company (NYSE:BDX)
Source:
DateHeadline
finance.yahoo.com logoBecton, Dickinson & Co. :BDX-US: Earnings Analysis: Q3, 2017 By the Numbers : September 21, 2017
finance.yahoo.com - September 21 at 4:14 PM
finance.yahoo.com logoBD (BDX) Inks New Deal to Strengthen Foothold in STI Space
finance.yahoo.com - September 21 at 11:48 AM
nasdaq.com logoBD, Euroclone Announce Development And Global Distribution Agreement
www.nasdaq.com - September 20 at 5:16 PM
finance.yahoo.com logoBD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sexually-Transmitted Pathogens
finance.yahoo.com - September 20 at 5:16 PM
finance.yahoo.com logoBD Introduces New 6mm Pen Needle for Injection Pens
finance.yahoo.com - September 19 at 4:28 PM
finance.yahoo.com logoBecton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : September 14, 2017
finance.yahoo.com - September 14 at 5:05 PM
americanbankingnews.com logoPiper Jaffray Companies Reaffirms "Buy" Rating for Becton, Dickinson and Company (BDX)
www.americanbankingnews.com - September 12 at 5:08 PM
zacks.com logoBecton, Dickinson's (BCR) C.R. Bard Buyout Plans Bode Well
www.zacks.com - September 12 at 4:39 PM
reuters.com logoBRIEF-Becton Dickinson and Co announces launch of platform for RNA expression analysis
www.reuters.com - September 12 at 4:39 PM
finance.yahoo.com logoBD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
finance.yahoo.com - September 12 at 4:39 PM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - September 12 at 9:02 AM
americanbankingnews.com logoInsider Selling: Becton, Dickinson and Company (BDX) Insider Sells 15,512 Shares of Stock
www.americanbankingnews.com - September 11 at 4:36 PM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) Insider Stephen Sichak Sells 11,787 Shares
www.americanbankingnews.com - September 11 at 10:32 AM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) Expected to Announce Quarterly Sales of $3.13 Billion
www.americanbankingnews.com - September 10 at 8:10 AM
finance.yahoo.com logoBD to Present at the Morgan Stanley Global Healthcare Conference 2017
finance.yahoo.com - September 8 at 4:49 PM
americanbankingnews.com logo$2.37 EPS Expected for Becton, Dickinson and Company (BDX) This Quarter
www.americanbankingnews.com - September 8 at 4:20 AM
nasdaq.com logoiShares Edge MSCI Min Vol USA ETF Experiences Big Inflow - Nasdaq
www.nasdaq.com - September 7 at 2:28 AM
nasdaq.com logoBecton, Dickinson and Company (BDX) Ex-Dividend Date Scheduled for September ...
www.nasdaq.com - September 6 at 4:24 PM
finance.yahoo.com logoBecton Dickinson Trying To Close In On Key Technical Benchmark
finance.yahoo.com - September 6 at 4:24 PM
finance.yahoo.com logoDividend Coverage: This Medical Tech Company has Raised Dividend for 45 Consecutive Years; Will Trade Ex-Dividend on September 07, 2017
finance.yahoo.com - September 6 at 4:24 PM
businesswire.com logoNorth America Infusion Systems Market Outlook to 2023: Key Players are Hospira Inc, Becton Dickinson and Co, Baxter International Inc & Medtronic plc - Research and Markets
www.businesswire.com - September 2 at 1:42 AM
finance.yahoo.com logoBecton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : August 31, 2017
finance.yahoo.com - August 31 at 4:22 PM
finance.yahoo.com logoHow Innovation Is Driving Becton Dickinson’s Growth in 2017
finance.yahoo.com - August 29 at 4:47 PM
finance.yahoo.com logoBeckton Dickinson: Key Highlights of 3Q17 Results
finance.yahoo.com - August 28 at 4:29 PM
finance.yahoo.com logoHeadwind for Becton Dickinson: US Dispensing Business
finance.yahoo.com - August 28 at 4:29 PM
finance.yahoo.com logoMedtronic Beats Earnings Estimates, Misses Revenue Estimates
finance.yahoo.com - August 25 at 6:12 PM
americanbankingnews.com logoFY2017 EPS Estimates for Becton, Dickinson and Company (BDX) Raised by Analyst
www.americanbankingnews.com - August 24 at 7:58 AM
americanbankingnews.com logoLinda M. Tharby Sells 4,695 Shares of Becton, Dickinson and Company (BDX) Stock
www.americanbankingnews.com - August 23 at 7:44 PM
americanbankingnews.com logoGary M. Cohen Sells 15,044 Shares of Becton, Dickinson and Company (BDX) Stock
www.americanbankingnews.com - August 23 at 7:20 PM
finance.yahoo.com logoBecton, Dickinson & Co. – Value Analysis (NYSE:BDX) : August 21, 2017
finance.yahoo.com - August 22 at 10:11 PM
finance.yahoo.com logoBecton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : August 21, 2017
finance.yahoo.com - August 21 at 4:27 PM
americanbankingnews.com logo$2.38 EPS Expected for Becton, Dickinson and Company (BDX) This Quarter
www.americanbankingnews.com - August 20 at 12:28 PM
News IconBecton Dickinson blood tubes not linked to inaccurate lead results: FDA
www.businessinsider.com - August 18 at 9:32 PM
seekingalpha.com logoBecton, Dickinson and Company 2017 Q3 - Results - Earnings Call Slides
seekingalpha.com - August 18 at 9:32 PM
seekingalpha.com logoTexas court rules that Retractable Tech gets nothing in BD suit, dismisses case; shares down 42% - Seeking Alpha
seekingalpha.com - August 18 at 4:32 PM
finance.yahoo.com logoFDA probes possible Becton Dickinson link to faulty lead tests (Aug. 17)
finance.yahoo.com - August 18 at 4:32 PM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 18 at 8:38 AM
finance.yahoo.com logoHow Varian Is Harnessing Proton Therapy Market Opportunities
finance.yahoo.com - August 16 at 5:02 PM
americanbankingnews.com logoInsider Selling: Becton, Dickinson and Company (BDX) Insider Sells 6,149 Shares of Stock
www.americanbankingnews.com - August 16 at 1:40 PM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) EVP Sells $1,503,122.83 in Stock
www.americanbankingnews.com - August 14 at 10:32 PM
finance.yahoo.com logoVarian Medical Systems: Better Aligned, More Focused
finance.yahoo.com - August 14 at 4:48 PM
finance.yahoo.com logoA Look at Varian Medical Systems’ Long-Term Goals
finance.yahoo.com - August 14 at 4:48 PM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) Receives Buy Rating from Cowen and Company
www.americanbankingnews.com - August 14 at 4:18 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Becton Dickinson and Co.
finance.yahoo.com - August 12 at 4:09 PM
nasdaq.com logoCamden Asset Management L P Buys Becton, Dickinson and Co, Great Plains Energy Inc, Stanley ...
www.nasdaq.com - August 11 at 4:56 PM
nasdaq.com logoCamden Asset Management L P Buys Becton, Dickinson and Co, Great Plains Energy Inc, Stanley ...
www.nasdaq.com - August 11 at 4:56 PM
finance.yahoo.com logoIHS Markit Score Update: Rise in demand for ETFs holding Becton Dickinson and Co is a positive for its shares
finance.yahoo.com - August 11 at 4:56 PM
finance.yahoo.com logoIHS Markit Score Update: Rise in demand for ETFs holding Becton Dickinson and Co is a positive for its shares
finance.yahoo.com - August 11 at 4:56 PM
americanbankingnews.com logoInsider Selling: Becton, Dickinson and Company (BDX) Insider Sells 9,283 Shares of Stock
www.americanbankingnews.com - August 11 at 1:22 PM
finance.yahoo.com logoIHS Markit Score upgrades Becton Dickinson and Co to 71 out of 100, ranking positively in one IHS Markit category.
finance.yahoo.com - August 11 at 3:44 AM

Social

Chart

Becton, Dickinson and Company (BDX) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by MarketBeat.com Staff